vendredi 7 juin 2013

Press Review (June 8, 2013) – Revue de presse (8 juin 2013)




Komen Breast Cancer Charity Cancels Races in 7 Cities
The Susan G. Komen for the Cure foundation has canceled half of its “3-Day” fund-raising races around the country next year as it struggles to regain support nearly 18 months after its 2012 decision to withdraw funding for breast cancer screening at some Planned Parenthood affiliates.
By Jennifer Preston. In New York Times (blog)

Nontoxic cancer therapy proves effective against metastatic cancer
A combination of nontoxic dietary and hyperbaric oxygen therapies effectively increased survival time in a mouse model of aggressive metastatic cancer, a research team from the Hyperbaric Biomedical Research Laboratory at the University of South Florida has found.
In Science Daily                                                

Cancer treatments still caught in sequestration politics
The Obama administration says it does not have the power to ease the cuts, leaving it to Congress to act.
By Katie McDonough. In Salon                          

Genetic Testing of Rare Blood Cancer Reveals New Mutation
A recent article in the New England Journal of Medicine describes genetic testing of a rare blood cancer called atypical chronic neutrophilic leukemia (CNL) that revealed a new mutation present in most patients with the disease. The mutation also serves as an Achilles heel, allowing doctors at the University of Colorado Cancer Center to prescribe a never-before-used, targeted treatment. The first patient treated describes his best snowboarding season ever.
In Science Daily                                                

World’s Oldest Cancer Found in Bone of 120,000 Year-Old Neanderthal
The world's oldest known human tumour has been found in the rib bone of a Neanderthal who lived more than 120,000 years ago.

The bone was evacuated from a site in Krapina, Croatia more than 100 years ago and has been found to have contracted the fibrous dysplasia  tumour, a cancer which is common among modern-day humans.
By Ewan Palmer. In International Business Times 

Une nouvelle arme contre le cancer du col de l'utérus ?
Des chercheurs viennent de mettre au point une stratégie pour stopper le développement du cancer du col de l’utérus, causé par certains papillomavirus. Cette méthode est basée sur l’utilisation d’une molécule d’ARN synthétique qui bloque l’action d’une protéine virale.
Par Agnès Roux. Dans Futura-Sciences

Le rôle de l'oestrogène mieux compris dans le cancer colorectal
Le cancer colorectal touche surtout les personnes de plus de 50 ans, un peu plus d'hommes que de femmes. C'est un cancer qui se développe sur plusieurs années – parfois même sur 20 ans – et qui reste discret très longtemps. En 2012 au Québec, on estime qu'il y a eu quelque 6200 nouveaux cas diagnostiqués et environ 2400 décès. Les facteurs de risque peuvent varier: polypes colorectaux, antécédents familiaux, mauvaises habitudes alimentaires (trop de viande rouge, pas assez de fruits et légumes), manque d'exercice physique et obésité. L'importance de la recherche sur le cancer colorectal est donc implicite.
Dans Techno-science.net



Aucun commentaire:

Enregistrer un commentaire